Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Sep 19.
Published in final edited form as: J Undergrad Chem Res. 2009 Summer;8(3):74–77.

THERMODYNAMIC CHARACTERIZATION OF METAL PHTHALOCYANINES-HUMAN SERUM ALBUMIN INTERACTIONS

Cecil L Jones 1, Chakeeta Jones 1,, Lana Thomas 1,
PMCID: PMC3777622  NIHMSID: NIHMS386292  PMID: 24058291

Abstract

The temperature dependence of the binding constants for human serum albumin and sulfonated metal-phthalocyanines were estimated by fluorescence spectroscopy. Stern-Volmer’s analysis and Chipman’s fits provided binding data for van’t Hoff calculations of the thermodynamic parameters governing these interactions. Results show that the formations of the HSA- phthalocyanine complexes are favorable processes by both the ΔH° and ΔS°. However, the formation of HSA-AIPcS4 has a stronger dependence than HSA-ZnPcS 4on ΔS°.

Keywords: Thermodynamics, Phthalocyanines, Stern-Volmer’s analysis, Fluorescence, van’t Hoff analysis, Dissociation constant, Photodynamic therapy

Introduction

Chemical thermodynamics enables one to predict the spontaneous direction of chemical reactions and to determine the driving forces governing the interactions (13). Two thermodynamic parameters of interest are the enthalpy change (ΔH) and the entropy change (ΔS). The enthalpy change is a measure of heat exchange between the system and surroundings under constant pressure conditions. The entropy measures the change in randomness or disorder associated with the chemical event. The Gibbs free energy change (ΔG) ultimately determines the direction of the reaction. The relationship between ΔG, ΔH, and ΔS is given by:

ΔG=ΔHTΔS (1)

where T is the temperature measured in Kelvin. A given reaction proceeds spontaneously in the forward direction when ΔG is negative and in the reverse direction if positive. If ΔG is zero, then the reaction is said to be in a state of dynamic equilibrium. This steady state condition refers to a system wherein the rate of the forward reaction is exactly equal to the rate of the reverse reaction.

The following equation depicts the interaction between a protein and ligand:

P+L=PL (2)

The reaction quotient is given by the ratio of product concentration to reactant concentration at any time during the course of the reaction:

Q=[PL]/[P][L] (3)

For a reversible reaction that has not reached equilibrium, the relationship between the free energy and reaction quotient (Q) is given by:

ΔG=ΔG°+RT ln Q (4)

where R is equal to the gas constant (8.31 J K−1 mol−1). Under steady-state conditions ΔG is zero and the reaction quotient becomes the equilibrium constant (Keq) resulting in an expression that allows the investigator to study the energetics of chemical binding:

ΔG°=RT ln Keq=ΔH°TΔS° (5)

The Keq measures the “tightness of binding” between the protein and ligand, such that large values of Keq indicate the formation of a strongly bonded protein-ligand complex (PL). A thorough analysis of the thermodynamic parameters will elucidate key information about forces that mediate binding (4). Protein-ligand binding is governed by a number of weak forces such as hydrogen bonding, electrostatic interactions, hydrophobic interactions and van der Waals Forces. The magnitude and sign of ΔH and ΔS will provide information associated with these forces. The compensation between these thermodynamic quantities leads to the analysis of an additional parameter called the heat capacity change under constant pressure, ΔCp of a system. Large heat capacity changes are often linked to the removal of a hydrophobic surface from contact with water (5, 6).

Phthalocyanines are organic dyes that are similar in structure to porpryins and are under extensive investigation for their application in photodynamic therapy (PDT). PDT is a noninvasive technique for shrinking both malignant and non-malignant solid tumors. The technique works by introducing a dye-like compound to the tumor tissue and then activating it with light of appropriate energy. Once activated, the dye (photosensitizer) transfers some of its energy to triplet oxygen 3O2, which is abundant in cancerous tissue, and converts it to singlet oxygen, 1O2. Highly reactive 1O2 is capable of disrupting a wide range of interactions critical to cell survival. Tissue subjected to a light activated photosensitizer will ultimately succumb to cell death via necrosis or apoptosis (711).

One of the key problems with the application of PDT is selectivity. FDA approved photosensitizer accumulates preferentially in cancerous-to-normal tissue at a current ratio of about 2:1. Human serum albumin (HSA) is widely recognized as a transport protein for various drugs including photosensitizers (12,13). Elucidating the nature of the interactions between HSA and various photosensitizers is critical to improving the selectivity of PDT. This work investigated the energetics of tetrasulfonic acids of aluminum phthalocyanine chloride (AIPcS4) and zinc II phthalocyanine (ZnPcS4) binding to HSA.

Experimental

Materials & Equipment

All glassware was scrupulously cleaned with detergent, soaked in 3.0 M HCl solution, and rinsed with distilled water prior to use. Adjustments to buffer pH were made using an Orion Expandable Ion Analyzer EA 920 pH meter. The pH meter was calibrated between two buffer solutions prior to measurements. Tetrasulfonic acids of aluminum phthalocyanine chloride (AIPcS4) and zinc II phthalocyanine (ZnPcS4) were purchased (Frontier Scientific, Logan, Utah). Photosensitizers should be handled only while wearing proper eye protection, safety gloves, and garments. All other chemicals were purchased (Sigma-Aldrich Corp., St. Louis, MO). A Varian Cary 100 spectrophotometer was used for UV/Vis measurements. The emission spectra were recorded with a Varian Cary Eclipse Bio-Melt Fluorescence Spectrophotometer using 10 mm pathlength cells.

Results and Discussion

An absorption spectrum of ZnPcS4 was recorded with the UV/Vis spectrophotometer to determine the wavelength of maximum absorbance (λmax = 636 nm). This wavelength was used to excite the photosensitizer and record a fluorescence emission spectrum. Figure 1 shows the fluorescence (middle curve) of the photosensitizer as well as the emission spectrum for HSA (bottom curve). HSA did not produce a signal over the spectral region shown in Figure 1 because the only intrinsic florophore in the protein is a single tryptophan residue (Tip214), which emits at around 350 nm. Note the large increase in emission associated with combining the HSA and the photosensitizer (top curve). The large signal observed at about 688 nm suggests the formation of a complex that substantially enhances the emission characteristics of the photosensitizer. This wavelength was used to measure the binding of HSA to the photosensitizer over a range of several temperatures.

Figure 1.

Figure 1

Fluorescence signal of HSA (bottom curve), ZnPcS4 (middle curve), and ZnPcS4 mixed with HSA (top curve).

The concentration of ZnPcS4 was held constant at 800 nM and titrated with HSA. A fluorescence spectrum was recorded over the temperature range of 20.0 to 55.0°C in increments of 5.0°C. The signal at 688 nm continued to increase with increasing concentration of the protein and trended toward an asymptotic point that indicated the completion of reaction. Figure 2 shows a Chipman’s Fit (Equation #6) of the emission maximum verses the concentration of HSA at 40.0°C. All data recorded for the titration of ZnPcS4 with HSA were fitted similarly to obtain temperature dependent dissociation constants, Kd. The natural log of binding constants, KB were calculated (1/Kd) and plotted as a function of inverse temperature for a van’t Hoff analysis. The dissociation constants where determined by Chipman’s Analysis (14):

F=F0+FKd[L]1+Kd  [L] (6)

where F0, F, and [L] represents the signal in the absence of protein, the asymptotic signal, and the protein concentration respectively.

Figure 2.

Figure 2

Chipman’s fit for the fluorescence of 800 nM ZnPcS4 titrated with HSA as a function of temperature.

It can be seen in Table 1 that an increase in the dissociation constant occurs with increasing temperature. This is expected because high temperatures disrupt the weak forces responsible for the formation of the protein-ligand complex.

Table 1.

The data for ZnPcS4 titrated with HSA as a function of temperature. Data for van’t Hoff Plot of ZnPcS4-HSA Interaction.

T (°C) 1/T (K−1) • 10−3 Kd ln(KB)
20 3.41 0.541 14.430
25 3.36 0.576 14.367
30 3.30 0.746 14.108
35 3.25 0.748 14.106
40 3.19 0.866 13.959
45 3.14 0.994 13.822
50 3.09 1.24 13.600
55 3.05 1.35 13.515

A van’t Hoff plot for HSA-ZnPcS4 binding is shown in Figure 3. The van’t Hoff equation is in the form of a linear curve (Equation 7) with the enthalpy change and entropy change provided by the slope (−ΔH°/R) and the y-intercept (ΔS°/R) respectively.

ln KB=ΔH°RT+ΔS°R (7)

Figure 3.

Figure 3

The van’t Hoff analysis of ZnPcs4, binding with HAS.

Using the gas constant R = 8.314 J mol−1 K−1 (1.987 cal mol−1 K−1), the enthalpy change and entropy change for the formation of HSA-ZnPcS4 complex are −21.2 ± 0.2 kJ/mol and 47.9 ± 0.5 J mol−1 K−1 respectively.

A similar experiment was conducted for investigating the interaction of HSA with AIPcS4. The data for this system is provided in Table 2. A Stern-Volmer analysis was used to fit this data because a decrease in the emission signal for HSA (quenching Trp214) was observed as a function of ligand concentration. The Stern-Volmer plot (Equation 8) is shown in Figure 4. The quenching or binding constant is given by:

F0F=11+KB[L] (8)

where F0 and F are the fluorescence intensities in the absence and presence of quenching ligand respectively (1517).

Table 2.

The data for AIPcS4 titrated with HSA as a function of temperature. Data for van’t Hoff Plot of AIPcS4-HSA Interaction.

T (K) 1/T (K−1)•10−3 Kd (µM) ln(KB)
293 3.41 0.847 13.982
298 3.36 0.885 13.938
303 3.30 0.855 13.972
308 3.25 0.909 13.910
313 3.19 0.952 13.865
318 3.14 0.971 13.845
323 3.09 1.02 13.796
328 3.05 1.13 13.693

Figure 4.

Figure 4

Stern-Volmer analysis of HSA-AIPcS4 interaction at 55.0 °C.

The enthalpy and entropy changes obtained from the van’t Hoff analysis shown in Figure 5 are −5.9 ± 0.1 kJ mol−1 and 96.4 ± 0.4 kJ mol−1 K−1 respectively.

Figure 5.

Figure 5

The van’t Hoff analysis of AIPcS4 binding with HSA.

Reactions of both ZnPcS4 and AIPcS4 with serum albumin are thermodynamically favorable with regard to ΔH° and ΔS°. The larger negative ΔH° for ZnPcS4 binding to HSA suggests that a combination of hydrogen-bonding and electrostatic interactions may be contributing to the stability of the complex. Electrostatic interactions, however, are generally believed to contribute little to the ΔH° (18, 19). The effects of ionic strength on these interactions may provide additional information regarding the difference in magnitude of ΔH° for the HSA complexed phthalocyanines of Al3+ and Zn2+. Solution dynamics seem to play a stronger role for binding between AIPcS4-HSA as indicated by a larger ΔS°. The magnitude of ΔS° for AIPcS4-HSA binding makes it the more thermodynamically favorable interaction. The effects of pH and ionic strength may provide additional insight into the mechanism of HSA interactions with sulfonated metal-phthalocyanines.

Table 3.

Thermodynamics of Sulfonated Phthalo-cyanines Binding to Human Serum Albumin.

ZnPcS4-HSA AIPcS4-HSA
ΔH°
(kJ·mol−1)
ΔS°
(J·mol−1 K−1)
ΔH°
(kJ·mol−1)
ΔS°
(J·mol−1 K−1)
−21.2 ± 0.2 47.9 ± 0.5 −5.9 ± 0.1 96.4 ± 0.4

Acknowlegements

Title III, the Peach State Louis Stokes Alliance for Minority Participation (PSLSAMP) Program, Savannah State University Department of Natural Science & Mathematics.I am also thankful for the loving support of Wubalem, Tia, Haymanot, Shatari, and Sintayehu Jones.

References

  • 1.Raffa RB. Drug-Receptor Thermodynamics Introduction and Applications. New York, USA: John Wiley & Sons, LTD; 2001. pp. 1–12. [Google Scholar]
  • 2.Hammes GG. Thermodynamics and Kinetics for the Biological Sciences. New York, USA: John Wiley & Sons, Inc.; 2000. pp. 124–151. [Google Scholar]
  • 3.Klotz IM. Ligand-Receptor Energetics: A Guide for the Perplexed. New York, USA: John Wiley & Sons, LTD; 1997. pp. 74–108. [Google Scholar]
  • 4.Komath SS, Kenoth R, Swamy MJ. Eur. J. Biochem. 2001;268:111–119. doi: 10.1046/j.1432-1327.2001.01852.x. [DOI] [PubMed] [Google Scholar]
  • 5.Spolar RS, Livingstone JR, Record MT. Biochem. 1992;31:3947–3955. doi: 10.1021/bi00131a009. [DOI] [PubMed] [Google Scholar]
  • 6.Vander Meulen KA, Saecker RM, Record MT. J. Mol. Biol. 2008;337:9–27. doi: 10.1016/j.jmb.2007.11.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Allison RR, Dowine GH, Cuenca R, Hu X, Childs CJ, Sibata CH. Photodiagn. Photodyn. Ther. 2004;1:27–42. doi: 10.1016/S1572-1000(04)00007-9. [DOI] [PubMed] [Google Scholar]
  • 8.Lambrechts SAG, Aalders MCG, Verbraak FD, Lagerberg JWM, Dankert JB, Schuitmaker JJ. J. Photochem. Photobiol.B. 2005;79:51–57. doi: 10.1016/j.jphotobiol.2004.11.020. [DOI] [PubMed] [Google Scholar]
  • 9.Philips D. Pure & Appl. Chem. 1995;67(1):117–126. [Google Scholar]
  • 10.Berg K, Selbo PK, Weyergang A, Dietze A, Prasmickaite L, Bonsted A, Engesaeter BO, Angellpetersen E, Warloe T, Frandsen N, Hogset A. J. Microsc. 2005;218(2):133–147. doi: 10.1111/j.1365-2818.2005.01471.x. [DOI] [PubMed] [Google Scholar]
  • 11.Niedre M, Patterson MS, Wilson BC. Photochem. Photobiol. 2002;75(4):382–391. doi: 10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 12.Chadborn N, Bryant J, Bain AJ, O’Shea P. Biophys. J. 1999;76:2198–2207. doi: 10.1016/S0006-3495(99)77375-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cohen S, Margalit R. Biochem. J. 1990;270:325–330. doi: 10.1042/bj2700325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chipman DM, Grisaro V, Sharon N. J. Biol. Chem. 1967;242:4388–4394. [PubMed] [Google Scholar]
  • 15.Jones CL, Grier K, Frazier K. J. Und. Chem. Res. 2008;7(1):43–47. [Google Scholar]
  • 16.Lakowicz JR. Principles of Fluorescence Spectroscopy. 2nd Ed. New York, USA: Kluwer Academic/Plenum Publishers; 1999. pp. 237–264. [Google Scholar]
  • 17.Khan SN, Islam B, Khan AU. Int. J, Integrative Biol. 2007;1(2):102–112. [Google Scholar]
  • 18.Ross PD, Subramanian S. Biochemistry. 1981;20:3096–3102. doi: 10.1021/bi00514a017. [DOI] [PubMed] [Google Scholar]
  • 19.Aki H, Yamamoto M. J. Pharm. Pharmacol. 1989;41:674–679. doi: 10.1111/j.2042-7158.1989.tb06339.x. [DOI] [PubMed] [Google Scholar]

RESOURCES